People · Operator

Moshe E. Barkan

Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology

1
Companies
1
Filings
$9.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
BacterioScan, Inc.BiotechnologySeries A$9.5M$61.5M2015
Operator network

Moshe E. Barkan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Richard R. Vietor · 2 companies · 1 sharedRichard R. VietorAmnon A. Weischelbaum · 1 companies · 1 sharedAmnon A. Weischel…Amnon R. Weischelbaum · 1 companies · 1 sharedAmnon R. Weischel…Dana A. Marshall · 1 companies · 1 sharedDana A. MarshallDana Marshall · 1 companies · 1 sharedDana MarshallDaniel A. Hofmann · 1 companies · 1 sharedDaniel A. HofmannFreddy A. Zinger · 1 companies · 1 sharedFreddy A. ZingerGreg R. Hewett · 1 companies · 1 sharedGreg R. HewettJaime A. De La Zerda · 1 companies · 1 sharedJaime A. De La Ze…James R. Brigham, Jr. · 1 companies · 1 sharedJames R. Brigham,…Michael E. Thaman · 1 companies · 1 sharedMichael E. ThamanMoshe R. Barken · 1 companies · 1 sharedMoshe R. BarkenRhonda E. Soest · 1 companies · 1 sharedRhonda E. SoestWilliam R. Marshall · 1 companies · 1 sharedWilliam R. Marsha…BacterioScan, Inc. · $9.5M raisedBacterioScan, Inc.Moshe E. BarkanMB
Moshe E. Barkan Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Moshe E. Barkan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Richard R. Vietor12
Daniel A. Hofmann11
Michael E. Thaman11
Jaime A. De La Zerda11
Dana A. Marshall11
Amnon A. Weischelbaum11
Amnon R. Weischelbaum11
James R. Brigham, Jr.11
William R. Marshall11
Moshe R. Barken11
Rhonda E. Soest11
Greg R. Hewett11
Freddy A. Zinger11
Dana Marshall11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.